abstract |
The invention relates to compounds of the general formula (1), (see formula) (J) with the designations of the substituents R1, R2, Ar and X being mentioned in the descriptive part, and their physiologically compatible salts; The invention also relates to a method of producing said compounds, and the use thereof as medicaments; The compounds of the invention are inhibitors of p011 (ADP-ribose) polymerase (PARP). |